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Dand support tissue-engineered heart constructs. This article con-
tains additional data of our experience decellularizing and testing
structural integrity and composition of a large series of human
hearts, “Acellular human heart matrix: a critical step toward whole
heat grafts” (Sanchez et al., 2015) [1]. Here we provide the infor-
mation about the heart decellularization technique, the valve
competence evaluation of the decellularized scaffolds, the integrity
evaluation of epicardial and myocardial coronary circulation, the
pressure volume measurements, the primers used to assess cardiac
muscle gene expression and, the characteristics of donors, donor
hearts, scaffolds and perfusion decellularization process.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biologyore speciﬁc sub-
ject areaBioengineering human heart matrixype of data Table, image, text ﬁle, ﬁgure
ow data was
acquiredEchocardiography (General Electric), linear mixed-effects models (LME, S-Plus
version 8.0, Tibco Software) and angiography (Siemens)ata format Analyzed, processed
xperimental
factorsHuman hearts used in the study were not suitable for transplantation.xperimental
featuresHeart decellularization perfusion was performed to remove cells but retain the
extracellular matrix scaffold. Characteristics of the scaffold valves, chambers and
vasculature were assessed using echocardiography, pressure-volume measure-
ments and coronary angiography. The effect of the human scaffold on the dif-
ferentiation of human cardiac progenitor cells was also analyzed with different
primersata source
locationMadrid, Spainata accessibility Within this articleValue of the data
 The data provides the schematic information of a decellularization heart perfusion technique that
could be followed as a standardized technique for additional decellularization studies.
 The data provides the detail information of the characteristics of donors and heart scaffolds. These
physiologic data will provide researchers with important age- and sex-speciﬁc reference ranges for
evaluating experimental results.
 It also provides the basis of different experiments for a clear demonstration of valve competence,
coronary angiography assessment and pressure-volume measurements. These novel assays could
be useful tools for the in vitro evaluation of decellularized heart scaffolds.
 The data provides the primers used to assess cardiac gene expression in human cardiac progenitor
cells grown on human decellularized extracellular matrices. The primers proﬁle data could be used
to identify cardiac cell differentiation.
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Dataset provided in this article shows the perfusion decellularization protocol we used to remove
the cells from 39 human hearts while retaining the extracellular matrix [1]. The characteristics of the
decellularized valves and anatomical aspects of the decellularized cardiac vessels were assessed by
using echocardiography and coronary angiography, respectively. In addition, the passive pressure-
volume relationship of the left and right ventricle was measured in 8 human hearts before and after
decellularization. Finally, primers used to assess cardiac gene expression in human cardiac progenitor
cells grown on human decellularized extracellular matrix are described.2. Experimental design, materials and methods
2.1. Heart decellularization technique
To remove cells but retain the extracellular matrix (ECM) we applied our previously described
perfusion decellularization technique, [2] with 1% sodium dodecyl sulfate (SDS) detergent in deio-
nized water via antegrade coronary perfusion of the ascending aorta. Schematic of perfusion decel-
lularization of human heart is shown in Fig. 1, Panel A. Perfusion pressure is monitored to perfuse the
heart at 80–100 mm Hg (normal blood pressure) and is changed by altering the height of the
dispensing container that feeds the decellularization or washing reagents into the aorta. During the
decellularization period (Fig. 1, Panels B to E) over 72–96 h, there is a loss of color as decellularization
proceeds ﬁrst from the thinnest regions (great vessels and atria) and progresses toward the thickest
areas of the heart so that the decellularized parts become more translucent and devoid of most color.Fig. 1. Heart decellularization technique.
Table 1
Characteristics of donors, donor hearts, scaffolds, and perfusion decellularization process.
Sex Age Heart
weight
Scaffold
weight
Time to start of
decellularization
Days of
decellularization
Male 50 558 452 9 h 4
Male 73 466 436 12 h 7
Female 58 332 224 24 h 4
Female 50 369 292 24 h 7
Male 80 398 327 24 h 7
Female 67 488 457 24 h 8
Female 87 358 Control Control Control
Female 35 267 Control Control Control
Female 54 587 522 9 h 7
Male 59 550 500 13 h 8
Male 49 380 351 8 h 4
Male 76 343 288 24 h 4
Female 68 526 432 3 days 5
Female 65 314 283 3 days 4
Female 17 231 189 8 h 5
Male 57 671 657 5 h 5
Male 66 435 344 24 h 4
Male 61 512 Control Control Control
Male 41 398 Control Control Control
Male 41 680 572 12 h 7
Female 72 284 Control Control Control
Male 43 353 300 24 h 4
Male 58 376 331 4 days 4
Male 59 432 376 24 h 4
Male 57 326 Control Control Control
Male 46 358 Control Control Control
Male 30 291 Control Control Control
Male 78 298 Control Control Control
Male 70 644 528 10 h 6
Male 78 430 354 5 days 4
Male 55 252 214 12 h 7
Female 32 271 171 12 h 3
Male 56 303 249 2 days 7
Female 60 404 334 60 h 5
Female 66 335 Control Control Control
Female 80 464 361 12 h 7
Male 58 419 279 10 h 6
Male 73 515 439 12 h 4
Male 52 457 435 18 h 8
Male 70 464 393 12 h 8
Male 52 565 373 24 h 6
Male 54 362 Control Control Control
Male 59 410 Control Control Control
Male 67 373 306 12 h 8
Female 64 305 244 12 h 8
Female 64 321 238 18 h 8
Female 63 526 418 18 h 4
Female 38 343 Control Control Control
Female 56 265 214 15 h 8
Female 65 327 295 18 h 8
Male 52 682 532 12 h 8
Male 70 677 525 12 h 8
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Characteristics of donors, donor hearts, scaffolds and perfusion decellularization process are
shown in Table 1. Thirty-nine human hearts were decellularized and 13 human hearts were used as
controls.
Fig. 2. Valve competence evaluation during systole and diastole using echocardiography from the epicardium.
Fig. 3. Angiographic coronary vascular study.
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Fig. 4. Pressure–volume measurement to assess global chamber mechanical passive properties.
Table 2
Primers used to assess cardiac muscle gene expression in hCPCs grown on human dECM for 21 days.
Gene Sense Anti-Sense
bMHC 50-GCTGGGGCTGATGCGCCTAT-30 50-TGGGGATGGGTGGAGCGCAA-30
cActin 50-GACGAGGAGACCACCGCCCT-30 50-ACCATAACTCCCTGGTGCCGC-30
GATA4 50-AGCAGCTTCTGCGCCTGTGG-30 50-TGGGGGCAGAAGACGGAGGG-30
MEF2C 50- TCCTGCAAATATGGCCCTAG-30 50- CCTGACACACCGGGATTGTT-30
Nkx2.5 50-TCACCGGCCAAGTGTGCGTC-30 50-GCAGCGCGCACAGCTCTTTC-30
Troponin T 50-GGAGCAGGAAGAAGCAGCTGTTGA-30 50-TTCTGCCCTGGTCTCCTCGGTC-30
GusB 50-CAACGAGCCTGCGTCCCACC-30 50-ACGGAGCCCCCTTGTCTGCT-30
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Macroscopic valve inspection was performed by cardiac surgeons and by echocardiography. Valve
obstruction was easily excluded by macroscopic valve inspection of the valves. The semilunar valves
(pulmonary and aortic) prevented retrograde ﬂow back into the ventricles by a simply maneuver of
ﬁlling with saline the ascending aorta and the pulmonary arteries. The atrioventricular valves (tri-
cuspid and mitral) were evaluated with echocardiography ﬁlling the LV and RV through a 5-French
intravascular sheath, inserted across the hermetically closed sutured aortic or pulmonary valves, with
isotonic saline using 60 ml syringes (Fig. 2). Systole and diastole was modiﬁed by aspiration or
injection of saline through the syringes helped by an external compression of the ventricles with the
hand. During echocardiography evaluation, the scaffolds were submerged in deionized water. We
obtained images with a broadband 14 MHz transducer (General Electric).
2.4. Integrity of epicardial and myocardial coronary circulation
Simultaneous angiography of the left and right coronary artery was assed to test the integrity of
epicardial and myocardial coronary circulation of the whole decellularized human hearts. Controls
Table 3
Critical steps and troubleshooting of decellularization technique and valve competence, coronary circulation and pressure-volume assessments.
Principal steps Trouble shooting Samples Homogeneity
Decellularization
technique
 Perfusion decellularization is performed with 1% sodium
dodecyl sulfate (SDS) detergent in deionized water via ante-
grade coronary perfusion through the ascending aorta.
Approximately 60 l of solution, during 4 days perfusion, is
needed to decelullarize a human heart.
 After SDS perfusion extensive rinsing with approximately 20 l
of water followed by 10 l of penicillin-streptomycin-containing
phosphate-buffered saline (PBS) is performed.
 The quality of SDS powder varies between brands. SDS solution
should be completely clear without aggregates.
 Pressure should be monitorized in order to avoid leaks through
the translucent wall chamber because of overpressure.
 Yellow-brown lipofuscin precipitates are observed within
decellularized myocardium if overpressure during antegrade
coronary perfusion
N¼39 Yes
Valve
competence
 Competency of valves was assed by macroscopic inspection,
by ﬁlling with saline the ascending aorta and pulmonary arteries
in the case of the semilunar valves (aortic and pulmonary), and by
echocardiography.
 To obtain adequate echocardiography images make sure the
heart scaffold is fully submerged in 36 °C deionized water.
N¼5 Yes
Coronary
circulation
 Left and right coronary ostium are cannulated with a conven-
tional cardiac surgery irrigating cannula. In our cases we used a
Debakey 3 mm cannula.
 The coronary sinus is also cannulated with a conventional
retrograde cannula in order to drain the injected
contrast media.
 An automatic contract injection was preferred over a manual
standard technique as it allowed us to control of injection rate
and amount of contrast to be delivered.
 Angiographic runs had to be long enough to allow ﬁlling of the
venous coronary system.
N¼5 Yes
Pressure-volume
assesment
 Ensure LV and RV are hermetically closed suturing all four
cardiac valves in a fully closed position.
 Soak the PV conductance catheter in a warm 36 °C saline for
30 min before measurements
 Pressure and volume are modiﬁed by aspiration, followed by
slow injection of isotonic saline with the use of 60 ml syringes.
 Ensure the PV conductance catheter has all sensing electrodes
within LV or RV. If all segments are not active adjust the catheter
position until all segments are active. Sometimes a slight twisting
of the catheter may be necessary to optimize loop morphology
 Pressure data were digitally acquired continuously whereas
volume was recoded at 1-mL intervals to obtain an optimal
conﬁguration.
 Ensure the contralateral ventricle is empty when PV measure-
ments are performed in the selected chamber.
N¼8 Yes
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P.L Sánchez et al. / Data in Brief 8 (2016) 211–219218and decellularized hearts were positioned in a foam mold, with a similar height to the anteroposterior
thorax length, where the heart shape was dug (Fig. 3, Panel A and B). To record the coronary
angiographic sequences we used an Artis Zee biplane system (Siemens Healthcare) (Fig. 3, Panel B).
Both coronary ostium were cannulated with a conventional irrigating DeBakey heparing cannula
(3 mm tip, 2 ½", 6.3 cm length, Pilling) and simultaneous angiography injections were performed
using a conventional mechanical injector pump (Fig. 3, Panel C-D). We also cannulated the coronary
sinus with a conventional retrograde cannula (Medtronic) in order to simultaneously drain the
injected contrast media (iodixanol, VisipaqueTM, General Electric).
2.5. Pressure–volume measurements
We studied the relative contributions of the ECM to overall passive mechanical global properties of
the left ventricle (LV) and right ventricle (RV) chambers. Mechanical properties of the decellularized
human hearts were compared to the intact heart before decellularization both for the LV and RV,
slightly modifying previously reported methods. [3–5] LV and RV are hermetically closed suturing
aortic (Fig. 4, Panel A), pulmonary, mitral and tricuspid valves in a fully closed position. A 5-French
intravascular sheath is inserted across the aortic (Fig. 4, Panel B) and pulmonary valve depending
whether LV or RV pressure-volume measurements are calculated. Non- compliant polyethylene
balloons are inserted across the aortic or pulmonary valves and hermetically attached to the 5-French
intravascular sheath because saline leakage was observed in scaffolds (Fig. 4, panel C). A 5-French
high-ﬁdelity micromanometer (Millar-Instrument) was placed inside the balloon and connected to a
3-port manifold (Fig. 4, Panel D). Pressure and volume are then modiﬁed by aspiration followed by
slow injection of isotonic saline using 60 ml syringes attached to the manifold (Fig. 4, Panel E). Dif-
ferences in repated measures obtained during pre- and post-decellularization of each specimen are
assessed by linear mixed-effects models (LME, S-Plus version 8.0, Tibco Software)(Fig. 2, Panel F).
2.6. Cardiac gene expression
Primers used to assess cardiac gene expression in human cardiac progenitor cells grown on human
decellularized ECM for 21 days are shown in Table 2.
2.7. Summarizing table
Table 3 summarizes critical steps and troubleshooting, number of samples analyzed and homo-
geneity results of the aforementioned principal protocols.Acknowledgment
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